Lamin A buffers CK2 kinase activity to modulate aging in a progeria mouse model.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30906869.
- Also identified by DOI 10.1126/sciadv.aav5078 and PMC identifier 6426468.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Defective nuclear lamina protein lamin A is associated with premature aging. Casein kinase 2 (CK2) binds the nuclear lamina, and inhibiting CK2 activity induces cellular senescence in cancer cells. Thus, it is feasible that lamin A and CK2 may cooperate in the aging process. Nuclear CK2 localization relies on lamin A and the lamin A carboxyl terminus physically interacts with the CK2α catalytic core and inhibits its kinase activity. Loss of lamin A in <i>Lmna</i>-knockout mouse embryonic fibroblasts (MEFs) confers increased CK2 activity. Conversely, prelamin A that accumulates in <i>Zmpste24</i>-deficent MEFs exhibits a high CK2α binding affinity and concomitantly reduces CK2 kinase activity. Permidine treatment activates CK2 by releasing the interaction between lamin A and CK2, promoting DNA damage repair and ameliorating progeroid features. These data reveal a previously unidentified function for nuclear lamin A and highlight an essential role for CK2 in regulating senescence and aging.
Medical subject headings
- Aging
- Casein Kinase II
- Lamin Type A
- Membrane Proteins
- Metalloendopeptidases
- Progeria